Cricket enthusiasts are electrified by news that Adar Poonawalla, CEO of India’s vaccine giant Serum Institute, plans to aggressively pursue ownership of IPL titleholders Royal Challengers Bengaluru. Ahead of IPL 2026, the franchise’s sale speculation has hit fever pitch.
Poonawalla shared his vision on X Thursday: ‘Getting ready for a powerful and competitive bid on RCB in the upcoming months. It’s among the IPL’s premier sides.’ This comes after RCB’s long-awaited 2025 IPL conquest, ending 17 years of frustration.
Captained by Rajat Patidar, RCB triumphed over Punjab Kings in the finale. Celebrations at Bengaluru’s Chinnaswamy Stadium on June 4 descended into horror when 300,000 fans caused a stampede outside, leading to 11 fatalities and over 50 injuries. The mishap has intensified pressure on current owners.
Past sale whispers never materialized, yet the title win, devoted fandom, and scandal have created ripe conditions for change. Homble Films, producer of Kantara and KGF under Vijay Kiragandur, is reportedly another contender.
RCB’s blend of stardom and market appeal positions it as IPL’s hottest property. Poonawalla’s deep pockets could stabilize operations and fuel ambitions for repeat glory, setting the stage for transformative shifts in franchise fortunes.